STOCK TITAN

Employers Expect Third Consecutive Year of Health Benefit Cost Increases Above 5% in 2025, According to Mercer

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Mercer's 2024 National Survey of Employer-Sponsored Health Plans reveals that US employers expect health benefit costs to rise 5.8% per employee in 2025, marking the third consecutive year of increases above 5%. Key findings include:

- Smaller employers (50-499 employees) face a potential 9% cost increase without mitigation measures
- Prescription drug costs continue to be the fastest-growing component, rising 7.2% in 2024
- 53% of employers plan to make cost-cutting changes to their plans in 2025, up from 44% in 2024
- Employees will contribute 21% of health insurance premiums through paycheck deductions in 2025

Factors driving higher costs include healthcare worker shortages, health system consolidation, and the introduction of high-cost gene and cellular therapies. Employers face the challenge of balancing healthcare affordability for employees with sustainable organizational spending.

Il Rapporto Nazionale 2024 di Mercer sui Piani Sanitari Sponsorizzati dai Datori di Lavoro rivela che i datori di lavoro statunitensi prevedono un aumento dei costi per i benefici sanitari del 5,8% per dipendente nel 2025, segnando il terzo anno consecutivo di aumenti superiori al 5%. Tra i principali risultati si evidenziano:

- I datori di lavoro più piccoli (50-499 dipendenti) potrebbero affrontare un aumento dei costi del 9% senza misure di mitigazione
- I costi dei farmaci da prescrizione continuano a essere la componente in più rapida crescita, con un incremento del 7,2% nel 2024
- Il 53% dei datori di lavoro prevede di apportare modifiche per ridurre i costi ai propri piani nel 2025, in aumento rispetto al 44% nel 2024
- I dipendenti contribuiranno per il 21% dei premi assicurativi attraverso detrazioni in busta paga nel 2025

I fattori che portano a un incremento dei costi includono la carenza di personale sanitario, la concentrazione del sistema sanitario e l'introduzione di terapie geniche e cellulari ad alto costo. I datori di lavoro devono affrontare la sfida di bilanciare l'adeguatezza dei costi sanitari per i dipendenti con la sostenibilità delle spese organizzative.

La Encuesta Nacional 2024 de Mercer sobre Planes de Salud Patrocinados por Empleadores revela que los empleadores estadounidenses esperan que los costos de los beneficios de salud aumenten un 5,8% por empleado en 2025, marcando el tercer año consecutivo de aumentos superiores al 5%. Los hallazgos clave incluyen:

- Los empleadores más pequeños (50-499 empleados) enfrentan un posible aumento de costos del 9% sin medidas de mitigación
- Los costos de los medicamentos recetados continúan siendo el componente de más rápido crecimiento, aumentando un 7,2% en 2024
- El 53% de los empleadores planea hacer cambios para reducir costos en sus planes en 2025, un aumento respecto al 44% en 2024
- Los empleados contribuirán con el 21% de las primas de seguros de salud a través de deducciones en sus cheques de pago en 2025

Los factores que impulsan el aumento de costos incluyen la escasez de trabajadores de la salud, la consolidación del sistema de salud y la introducción de terapias genéticas y celulares de alto costo. Los empleadores enfrentan el desafío de equilibrar la asequibilidad de la atención médica para los empleados con un gasto organizativo sostenible.

머서의 2024년 고용주 후원 건강 계획에 대한 국가 조사에 따르면 미국의 고용주들은 2025년에 직원 1인당 건강 복지 비용이 5.8% 증가할 것으로 예상하고 있습니다, 이는 5% 이상의 증가가 이어지는 세 번째 해를 나타냅니다. 주요 결과는 다음과 같습니다:

- 소규모 고용주(50-499명 직원)는 완화 조치 없이 9%의 잠재적 비용 증가에 직면하고 있습니다
- 처方약 비용은 2024년에 7.2% 증가하며 여전히 가장 빠르게 증가하는 구성 요소입니다
- 2025년에 53%의 고용주가 비용 절감을 위한 변화를 계획하고 있으며, 이는 2024년의 44%에서 증가한 수치입니다
- 직원들은 2025년에 급여 공제를 통해 건강 보험료의 21%를 분담할 것입니다

비용 증가를 유발하는 요인으로는 의료 종사자의 부족, 의료 시스템 통합, 고비용 유전자 및 세포 치료의 도입이 있습니다. 고용주들은 직원들을 위한 의료비 부담 가능성과 지속 가능한 조직 경비 사이의 균형을 맞추는 도전에 직면해 있습니다.

Le Sondage National 2024 de Mercer sur les Plans de Santé Sponsorisés par les Employeurs révèle que les employeurs américains s'attendent à une augmentation de 5,8% des coûts des prestations de santé par employé en 2025, marquant la troisième année consécutive d'augmentations supérieures à 5%. Les principales conclusions incluent:

- Les petits employeurs (50-499 employés) font face à une augmentation potentielle des coûts de 9% sans mesures d'atténuation
- Les coûts des médicaments sur ordonnance continuent d'être le composant à la croissance la plus rapide, augmentant de 7,2% en 2024
- 53% des employeurs prévoient d'apporter des changements pour réduire les coûts de leurs plans en 2025, contre 44% en 2024
- Les employés contribueront à 21% des primes d'assurance santé par le biais de déductions sur leur paie en 2025

Les facteurs qui entraînent des coûts plus élevés incluent la pénurie de personnel de santé, la consolidation du système de santé et l'introduction de thérapies géniques et cellulaires coûteuses. Les employeurs doivent faire face au défi de trouver un équilibre entre l'accessibilité des soins de santé pour les employés et des dépenses organisationnelles durables.

Die nationale Umfrage 2024 von Mercer zu arbeitgeberfinanzierten Gesundheitsplänen zeigt, dass US-Arbeitgeber im Jahr 2025 mit einem Anstieg der Gesundheitskosten um 5,8% pro Mitarbeiter rechnen, was das dritte aufeinanderfolgende Jahr mit Anstiegen über 5% bedeutet. Zu den wichtigsten Ergebnissen gehören:

- Kleinunternehmer (50-499 Mitarbeiter) sehen sich einer potenziellen Kostensteigerung von 9% ohne Maßnahmen zur Kostenminderung gegenüber
- Die Kosten für verschreibungspflichtige Medikamente bleiben der am schnellsten wachsende Bestandteil und steigen 2024 um 7,2%
- 53% der Arbeitgeber planen, im Jahr 2025 kostensenkende Änderungen an ihren Plänen vorzunehmen, ein Anstieg von 44% im Jahr 2024
- Mitarbeiter werden 2025 21% der Gesundheitsprämien über Gehaltsabzüge beitragen

Zu den Faktoren, die die höheren Kosten antreiben, gehören der Mangel an Gesundheitsdienstleistern, die Konsolidierung des Gesundheitssystems und die Einführung kostenintensiver Gen- und Zelltherapien. Arbeitgeber stehen vor der Herausforderung, die Bezahlbarkeit von Gesundheitsleistungen für die Mitarbeiter mit nachhaltigen Ausgaben der Organisation in Einklang zu bringen.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Today, Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people, released preliminary results from its 2024 National Survey of Employer-Sponsored Health Plans.

According to an analysis of responses from over 1,800 US employers, total health benefit cost per employee is expected to rise 5.8% on average in 2025, even after accounting for planned cost-reduction measures. Employers estimated that their cost would rise by about 7%, on average, if they took no action to lower cost. Smaller employers (those with 50-499 employees), which typically have fully insured health plans, have been hit the hardest. They reported that cost would rise by about 9% on average if they took no action to lower cost.

Based on these projections, 2025 would be the third consecutive year of health benefit cost increases above 5%, following a decade of cost increases averaging only around 3%. Meanwhile, general inflation has cooled, suggesting that other factors are contributing to the higher health benefit cost trend.

Complex forces driving higher cost trend

According to Sunit Patel, Mercer’s US Chief Actuary for Health and Benefits, several factors are contributing to faster cost growth. Mr. Patel said, “While we’ve seen significant increases in utilization in a few areas, such as for behavioral healthcare and GLP-1 medications, overall utilization has had a relatively modest impact on trend this year. The biggest driver of higher costs is price dynamics, some of which are macro in nature.”

One source of pricing pressure is the widening gap between the supply of healthcare workers and the demand for healthcare services, which is building as older Americans become a larger part of the population. Another is the continuing consolidation of health systems – which shows no sign of slowing down. Mr. Patel notes, “Consolidation may generate savings in the future through increased efficiency and improved integration, but there is evidence it is putting pressure on pricing, as larger health systems have greater negotiating power than smaller systems.”

Spending on prescription drugs remains the fastest-growing component of health benefit cost. Employers reported that drug benefit cost per employee rose 7.2% in 2024. The ongoing introduction of very high-cost gene and cellular therapies is contributing to this higher cost growth.

The employer response to faster cost growth

The survey results suggest that about half of employers (53%) will make cost-cutting changes to their plans in 2025, an increase from 44% in 2024. Generally, these changes involve raising deductibles and other cost-sharing provisions and result in higher out-of-pocket costs for plan members when they seek care. In recent years, many employers have avoided making these types of changes, but this becomes more difficult in a period of sustained higher cost growth.

According to Tracy Watts, Mercer’s National Leader of US Health Policy, “Employers are still concerned about healthcare affordability and ensuring that employees can afford the out-of-pocket costs when they seek care. But they also need to manage the overall cost of healthcare coverage to achieve a sustainable level of spending for the organization. Balancing these competing priorities will be a challenge over the next few years.”

Because the cost of healthcare coverage is typically shared between the employer and employee, managing cost is also important to minimize growth in employee premium contributions. On average, employees will pay for 21% of health insurance premiums through paycheck deductions in 2025, the same as in 2024.

About Mercer’s National Survey of Employer-Sponsored Health Plans

The 2024 National Survey of Employer-Sponsored Health Plans launched on June 12. The preliminary results are based on responses from over 1,800 employers through August 12. The final survey results, which will include about 2,200 employers, will be released later this year.

About Mercer

Mercer, a business of Marsh McLennan (NYSE: MMC), is a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of $23 billion and more than 85,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit mercer.com, or follow on LinkedIn and X.

Media:

Ashleigh Jang

Mercer

+1 917 647 0070

Ashleigh.Jang@mercer.com

Source: Mercer

FAQ

What is the expected increase in health benefit costs for US employers in 2025 according to Mercer's survey?

According to Mercer's 2024 National Survey of Employer-Sponsored Health Plans, US employers expect health benefit costs to rise 5.8% per employee on average in 2025, even after accounting for planned cost-reduction measures.

How much would health benefit costs rise for smaller employers (50-499 employees) in 2025 without cost-reduction actions?

Smaller employers with 50-499 employees reported that health benefit costs would rise by about 9% on average in 2025 if they took no action to lower costs.

What percentage of employers plan to make cost-cutting changes to their health plans in 2025?

The survey results indicate that 53% of employers plan to make cost-cutting changes to their health plans in 2025, an increase from 44% in 2024.

How much did prescription drug benefit costs per employee increase in 2024?

Employers reported that drug benefit cost per employee rose 7.2% in 2024, making it the fastest-growing component of health benefit costs.

What percentage of health insurance premiums will employees pay through paycheck deductions in 2025?

On average, employees will pay for 21% of health insurance premiums through paycheck deductions in 2025, which remains unchanged from 2024.

Marsh & McLennan Companies, Inc.

NYSE:MMC

MMC Rankings

MMC Latest News

MMC Stock Data

112.38B
492.72M
0.09%
90.97%
0.91%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States of America
NEW YORK